|
[1]
|
Huang, W., Liu, W., Xiao, Y., et al. (2020) Tripterygium and Its Extracts for Diabetic Nephropathy: Efficacy and Phar-macological Mechanisms. Biomedicine Pharmacotherapy, 121, Article ID: 109599. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Fang, G. and Tang, B. (2020) Current Advances in the Nano-Delivery of Celastrol for Treating Inflammation-Associated Diseases. Journal of Materials Chemistry B, 8, 10954-10965. [Google Scholar] [CrossRef]
|
|
[3]
|
Qiu, F., Xi, L., Chen, S., et al. (2021) Celastrol Niosome Hydrogel Has Anti-Inflammatory Effect on Skin Keratinocytes and Circulation without Systemic Drug Exposure in Pso-riasis Mice. International Journal of Nanomedicine, 16, 6171-6182. [Google Scholar] [CrossRef]
|
|
[4]
|
You, R., He, X., Zeng, Z., et al. (2022) Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. Fron-tiers in Immunology, 13, Article ID: 841732. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Li, X., Zhu, G., Yao, X., et al. (2018) Celastrol Induces Ubiquitin-Dependent Degradation of mTOR in Breast Cancer Cells. OncoTargets and Therapy, 11, 8977-8985. [Google Scholar] [CrossRef]
|
|
[6]
|
Zhu, Y., Liu, X., Zhao, P., et al. (2019) Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway. Frontiers in Pharmacology, 11, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Hsieh, M., Wang, C., Lin, J., et al. (2019) Celastrol, a Plant-Derived Triterpene, Induces Cisplatin-Resistance Nasopharyngeal Carcinoma Cancer Cell Apoptosis Though ERK1/2 and p38 MAPK Signaling Pathway. Phytomedicine, 58, Article ID: 152805. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Moreira, H., Szyjka, A., Paliszkiewicz, K., et al. (2019) Proox-idative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 6793957. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ma, L., Peng, L., Fang, S., et al. (2017) Celastrol Downregulates E2F1 to Induce Growth Inhibitory Effects in Hepatocellular Carcinoma HepG2 Cells. Onocology Reports, 38, 2951-2958. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Lu, Y., Liu, Y., Zhou, J., et al. (2021) Biosynthesis, Total Synthesis, Structural Modifications, Bioactivity, and Mechanism of Action of the Quinone-Methide Triterpenoid Celastrol. Medici-nal Research Reviews, 41, 1022-1060. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Renda, G., Gökkaya, I. and Şöhretoğlu, D. (2022) Immunomodulatory Properties of Triterpenes. Phytochemistry Reviews, 21, 537-563. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Weisberg, S., Leibel, R. and Tortoriello, D.V. (2016) Proteasome Inhibitors, Including Curcumin, Improve Pancreatic β-Cell Function and Insulin Sensitivity in Diabetic Mice. Nutrition & Diabetes, 6, e205. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Han, L., Li, C., Sun, B., et al. (2016) Protective Effects of Celastrol on Diabetic Liver Injury via TLR4/MyD88/NF-κB Signaling Pathway in Type 2 Diabetic Rats. Journal of Diabetes Re-search, 2016, Article ID: 2641248. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Guan, Y., Cui, Z., Sun, B., et al. (2016) Celastrol Attenuates Oxidative Stress in the Skeletal Muscle of Diabetic Rats by Regulating the AMPK-PGC1α-SIRT3 Signaling Pathway. International Journal of Molecular Medicine, 37, 1229-1238. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Bakar, M., Cheng, K., Sarmidi, M., et al. (2015) Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells. Molecules, 20, 8242-8269. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Raulin, J. (2002) Human Im-munodeficiency Virus and Host Cell Lipids. Interesting Pathways in Research for a New HIV Therapy. Progress in Li-pid Research, 41, 27-65. [Google Scholar] [CrossRef]
|
|
[17]
|
Narayan, V., Ravindra, K., Chiaro, C., et al. (2011) Celastrol Inhibits Tat-Mediated Human Immunodeficiency Virus (HIV) Transcription and Replication. Journal of Molecular Biology, 410, 972-983. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ryu, Y., Park, S., Kim, Y., et al. (2010) SARS-CoV 3CLpro In-hibitory Effects of Quinone-Methide Triterpenes from Tripterygium regelii. Bioorganic & Medicinal Chemistry Letters, 20, 1873-1876. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Prasad, P., Verma, S., Surbhi, et al. (2023) Rheumatoid Arthritis: Advances in Treatment Strategies. Molecular and Cellular Biochemistry, 478, 69-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Jing, M., Yang, J., Zhang, L., et al. (2021) Celastrol Inhibits Rheumatoid Arthritis through the ROS-NF-κB-NLRP3 Inflammasome Axis. International Immunopharmacology, 98, Article ID: 107879. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wong, K., Qiu, C., Xu, S., et al. (2019) Ca2+ Signalling Plays a Role in Celastrol-Mediated Suppression of Synovial Fibroblasts of Rheumatoid Arthritis Patients and Experimental Ar-thritis in Rats. Bangladesh Journal of Pharmacology, 176, 2922-2944. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
An, L., Li, Z., Shi, L., et al. (2020) Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways. Nano Letters, 20, 7728-7736. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Yang, J., Liu, J., Li, J., et al. (2022) Celastrol Inhibits Rheuma-toid Arthritis by Inducing Autophagy via Inhibition of the PI3K/AKT/mTOR Signaling Pathway. International Im-munopharmacology, 112, Article ID: 109241. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Lu, X., Gong, S., Wang, X., et al. (2021) Celastrol Exerts Car-dioprotective Effect in Rheumatoid Arthritis by Inhibiting TLR2/HMGB1 Signaling Pathway-Mediated Autophagy. In-ternational Archives of Allergy and Immunology, 182, 1245-1254. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Shirai, T., Nakai, A. ando, E., et al. (2023) Celastrol Suppresses Humoral Immune Responses and Autoimmunity by Targeting the COMMD3/8 Complex. Science Immunology, 8, eadc9324. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Liu, D., Zhang, B., Yang, J., et al. (2020) Celastrol Ameliorates Endoplasmic Stress-Mediated Apoptosis of Osteoarthritis via Regulating ATF-6/CHOP Signalling Pathway. Journal of Pharmacy and Pharmacology, 72, 826-835. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Fang, Z., He, D., Yu, B., et al. (2017) High-Throughput Study of the Ef-fects of Celastrol on Activated Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis. Genes (Basel), 8, 221. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Yao, C., Ye, W. and Chen, M. (2023) Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2. Disease Markets, 2023, Article ID: 9049256. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Zhou, L., Lin, Z., Fung, K., et al. (2011) Celastrol-Induced Apoptosis in Human HaCaT Keratinocytes Involves the Inhibition of NF-κB Activity. European Journal of Pharmacol-ogy, 670, 399-408. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Feng, K., Chen, H., Xu, C., et al. (2020) Chondro-Protective Ef-fects of Celastrol on Osteoarthritis through Autophagy Activation and NF-κB Signaling Pathway Inhibition. Inflamma-tion Research, 69, 385-400. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Yuan, X., Tang, B., Chen, Y., et al. (2023) Celastrol Inhibits Store Operated Calcium Entry and Suppresses Psoriasis. Frontiers in Pharmacology, 14, Article ID: 1111798. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Kuai, L., Ru, Y., Zhu, Q., et al. (2022) Celastrol Attenuates Pso-riasiform Inflammation by Targeting the IRF1/GSTM3 Axis. Journal of Investigative Dermatology, 142, 2281-2285. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Liu, L., Chen, X., Lu, Y., et al. (2022) Celastrol Gel Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice by Targeting Langerhans Cells. Biomedicine & Pharmacotherapy, 147, Article ID: 112644. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Nguyen, T., Lestienne, F., Cousy, A., et al. (2020) Effective In-hibition of Th17/Th22 Pathway in 2D and 3D Human Models of Psoriasis by Celastrol Enriched Plant Cell Culture Ex-tract. Journal of the European Academy of Dermatology and Venereology, 34, 3-9. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Zhang, J., Shan, J., Chen, X., et al. (2018) Celastrol Mediates Th17 and Treg Cell Generation via Metabolic Signaling. Biochemical and Biophysical Research Communications, 497, 883-889. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Xi, L., Lin, Z., Qiu, F., et al. (2022) Enhanced Uptake and An-ti-Maturation Effect of Celastrol-Loaded Mannosylated Liposomes on Dendritic Cells for Psoriasis Treatment. Acta Pharmaceutica Sinica B, 12, 339-352. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Web, G., Hirschfield, G., Krawitt, E., et al. (2018) Cellular and Molecular Mechanisms of Autoimmune Hepatitis. Annual Review of Materials Science, 13, 247-292. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wang, S., Huang, Z., Lei, Y., et al. (2022) Celastrol Alleviates Autoimmune Hepatitis through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Ex-periments. Frontiers in Pharmacology, 13, Article ID: 816350. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Zhang, T., Rao, Q., Dai, M., et al. (2023) Tripterygium wilfordii Protects against an Animal Model of Autoimmune Hepatitis. Journal of Ethnopharmacology, 309, Article ID: 116365. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Li, D., Chen, J., Lin, B., et al. (2023) Celastrol Pretreatment Attenu-ates Concanavalin A-Induced Hepatitis in Mice by Suppressing Interleukin-6/STAT3-Interleukin-17 Signaling. Journal of Gastroenterology Hepatology, 38, 821-829. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Lisnevskaia, L., Murphy, G. and Isenberg, D. (2014) Systemic Lupus Ery-thematosus. The Lancet, 384, 1878-1888. [Google Scholar] [CrossRef]
|
|
[42]
|
Xiang, G., Shi, K. and Wang, J. (2022) Celastrol Alleviates Murine lupus Nephritis via Inducting CD4+ Foxp3+ Regulatory T Cells. Folia Histochemica et Cytobiologica, 60, 237-246. [Google Scholar] [CrossRef]
|
|
[43]
|
Venkatesha, S. and Moudgil, K. (2019) Celastrol Sup-presses Experimental Autoimmune Encephalomyelitis via MAPK/SGK1-Regulated Mediators of Autoimmune Pathology. Inflammation Research, 68, 285-296. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Shao, H., Fan, W. and Tang, Y. (2023) Celastrol Attenuates Guillain-Barré Syndrome by Inhibiting TLR4/NF-κB/STAT3 Pathway-Mediated Th1/Th17 Cell Differentiation. General Physiology and Biophysics, 42, 13-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Xian, J., Zhong, X., Gu, H., et al. (2021) Colonic Delivery of Celastrol-Loaded Layer-by-Layer Liposomes with Pectin/Trimethylated Chitosan Coating to Enhance Its Anti-Ulcerative Colitis Effects. Pharmaceutics, 13, Article No. 2005. [Google Scholar] [CrossRef] [PubMed]
|